Amgen
AMGN
$297.03
Share price
0.60%
Change (1 day)
-10.03%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) - Total assets
Total assets on the balance sheet as of March 2025 : $89.36 Billion USD
According to Amgen's latest financial reports the company's total assets are $89.36 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Amgen - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $91.83 B | -5.47% |
| 2023-12-31 | $97.15 B | 49.19% |
| 2022-12-31 | $65.12 B | 6.47% |
| 2021-12-31 | $61.16 B | -2.83% |
| 2020-12-31 | $62.94 B | 5.43% |
| 2019-12-31 | $59.70 B | -10.1% |
| 2018-12-31 | $66.41 B | -16.93% |
| 2017-12-31 | $79.95 B | 3% |
| 2016-12-31 | $77.62 B | 8.65% |
| 2015-12-31 | $71.44 B | 3.54% |
| 2014-12-31 | $69.00 B | 4.36% |
| 2013-12-31 | $66.12 B | 21.78% |
| 2012-12-31 | $54.29 B | 11.1% |
| 2011-12-31 | $48.87 B | 12.38% |
| 2010-12-31 | $43.48 B | 9.73% |
| 2009-12-31 | $39.62 B | 8.74% |
| 2008-12-31 | $36.44 B | 5.21% |
| 2007-12-31 | $34.63 B | 2.52% |
| 2006-12-31 | $33.78 B | 15.33% |
| 2005-12-31 | $29.29 B | 0.26% |
| 2004-12-31 | $29.22 B | 11.9% |
| 2003-12-31 | $26.11 B | 6.78% |
| 2002-12-31 | $24.45 B | 279.57% |
| 2001-12-31 | $6.44 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $208.02 B | 132.78% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $92.42 B | 3.42% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $78.43 B | -12.23% | 🇬🇧 UK |
 Gilead Sciences GILD | $56.43 B | -36.85% | 🇺🇸 USA |
 Biogen BIIB | $28.03 B | -68.63% | 🇺🇸 USA |
 AbbVie ABBV | $136.16 B | 52.37% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $193.67 B | 116.71% | 🇺🇸 USA |
 Illumina ILMN | $6.18 B | -93.08% | 🇺🇸 USA |
 Eli Lilly LLY | $89.38 B | 0.02% | 🇺🇸 USA |